KeyCorp stock outperforms competitors on strong trading day
KeyCorp closed 11.57% short of its 52-week high of $20.04, which the company reached on November 25th.
Vera plunges as Otsuka updates on rival therapy
Vera Therapeutics (VERA) stock falls as Otsuka (OTSKF) updates on its IgA nephropathy therapy sibeprenlimab, which rivals ...
Why Structure Therapeutics Stock Was Stumbling This Week
One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Over 230 patients enrolled in potential registration-enabling trial in 1L HLA-A2-negative MUM, and median PFS readout targeted by year-end 2025 95 patients enrolled ...
Zacks.com on MSN2d
EXEL Tops Q4 Earnings and Sales, Cabometyx Label Expansion in Focus
Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 51 cents. The company registered ...
Merck (MRK) Downgraded by TD Cowen Over Keytruda, Gardasil Concerns
We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...